Looking for a used or new machine tool?
1,000s to choose from
Hurco MPU Bodor MPU Ceratizit MPU XYZ Machine Tools MPU TDT Machine Tools MPU

The online search from the pages of Machinery Market.

Year 2002. 
Heidenhain TNC410 control, 
16-station tool changer. 
TABLE 840 X 360 
Year 2002. Heidenhain TNC410 control, 8,000rpm, 16-station tool changer. TABLE 840 X 360 X...
Reid Machinery Sales

Be seen in all the right places!

Intermach 2020 Toolex 2020 Metal Show & TIB Manufacturing Surabaya 2020 MTA Hanoi ITM Industry Europe 2020 Advanced Engineering 2020 Metaltech 2020 Manufacturing & Supply Chain Expo Machine Tool Indonesia 2020 MACH 2021 FITMA 2021

Mologic awarded £1 million for coronavirus test

Posted on 30 Mar 2020 and read 608 times
Mologic awarded £1 million for coronavirus testMologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, has been awarded £1 million as part of the UK Government’s £46 million international coronavirus (COVID-19) prevention and research funding package.

The funding will be used by Mologic and global partners to develop a point-of-need diagnostic test for the virus — and to initiate research for new vaccine candidates.

Mologic (www.mologic.co.uk) will build on its experience of developing a rapid test kit for Ebola to create a new hand-held device to detect COVID-19.

This will allow health officials to test for the virus at home or in the community, providing results in 10min — without the need for electricity or a laboratory.

Mologic co-founder and chief scientific officer Paul Davis said: “As seen with the COVID-19 outbreak, viruses can quickly transmit between populations, but our knowledge to tackle this threat has also grown exponentially.

“For rapid epidemic preparedness and response, we need to develop a platform that is readily modified according to a novel pathogen, as we are demonstrating through our accelerated programmes for Ebola and COVID-19.”

Mologic medical director Joe Fitchett said: “The COVID-19 outbreak is at a critical juncture; to bring it to an end, we need next-generation diagnostics for use at the point-of-need — at home or in the community, in limited and well-resourced settings.

"Rapid detection of the virus is important to stop its spread; we are pleased that the UK Government has acknowledged this, supporting Mologic and the work of our partners to prevent further outbreaks internationally.”